Mary Doubleday

Title: The Innovative Contributions of Mary Doubleday

Introduction: Mary Doubleday, based in Snohomish, WA, is a notable inventor recognized for her significant contributions to pharmaceutical innovations. With a focus on squalamine dilactate, her work aims to address pressing medical challenges.

Latest Patents: Mary holds a patent related to "Polymorphic and Amorphous Salt Forms of Squalamine Dilactate." This invention outlines methods for synthesizing select squalamine salts, emphasizing their therapeutic use. The advantages of her work include improved manufacturing processes, enhanced product stability, and reduced toxicity. Specifically, her application targets various forms of the dilactate salt of squalamine and their efficacy in inhibiting neovascularization and endothelial cell proliferation.

Career Highlights: Throughout her career, Mary has focused on groundbreaking research and development in the pharmaceutical field. Her dedication to innovation has positioned her as a thought leader within her organization, Ohr Pharmaceutical Inc.

Collaborations: Mary has collaborated with esteemed colleagues such as Eric Chellquist and Charles W. Gilbert. These partnerships have enriched her work and contributed to the advancement of their shared goals in medical research.

Conclusion: Mary Doubleday's contributions to the field of pharmaceuticals through her patent for squalamine dilactate highlight the impact of innovation on healthcare. Her work not only advances our understanding of neovascularization but also presents new avenues for therapeutic applications. As an inventor, she exemplifies the importance of creativity and collaboration in driving scientific progress.